QR kód

Lebrikizumab ADvocate1 and 2 Monotherapy and ADjoin (Long-Term) Trials: Use of Topicals Therapies

Abstract Atopic dermatitis (AD) is a chronically relapsing, complex skin disease characterized mainly by skin lesions and itch. The first-line treatment for patients with AD includes topical therapy, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI). Long-term use of top...

Celý popis

Uloženo v:
Hlavní autoři: Linda Stein-Gold, Marjolein DeBruin-Weller, Diamant Thaci, Leon Kircik, Chao Yang, Maria Jose Rueda, Gaia Gallo, Amy Paller
Médium: Artigo
Jazyk:Inglês
Vydáno: Adis, Springer Healthcare 2026-05-01
Edice:Dermatology and Therapy
Témata:
Atopic dermatitis
Lebrikizumab
Topical corticosteroids
Moderate-to-severe
On-line přístup:https://doi.org/10.1007/s13555-026-01771-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky